-
-
-
-
-
-
-
Piper Sandler on Design Therapeutics Inc (DSGN): 'Execution Is Full Gear Mode With a Catalyst Rich 2H26'
-
-
-
-
-
-
-
Design Therapeutics Highlights Momentum Across Lead GeneTAC® Programs and Reports First Quarter 2025 Financial Results
-
-
-
-
-
-
-
Design Therapeutics Announces Second Quarter 2024 Financial Results and Reviews Near-term Milestones for GeneTACâ„¢ Portfolio
-
-
-
-
-
-
-
Design Therapeutics Reports Third Quarter 2023 Financial Results and Plans for a Comprehensive Portfolio Update in Early 2024
-
-
-
-
-
-
-
Design Therapeutics Highlights Pipeline Progress and Upcoming Milestones and Reports Third Quarter 2022 Financial Results
-
-
-
-
-
-
-
Design Therapeutics Reports Pipeline Progress and Third Quarter 2021 Results
-
-
-
-
-
1,217,618 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

